A healthy investment in healthier futures.

Cryo-Cell has been a publicly traded company since 1991. Governed by the Securities & Exchange Commission, our common stock trades under the OTC QB: symbol CCEL. We specialize in stem cell preservation for family use.
 
 

Key Stakeholders Support Cryo-Cell International Leadership in Proxy Contest

Individuals who are in the best position to observe and evaluate the performance of the current Cryo-Cell International [OTCQB Symbol: CCEL] Board and executive management are strongly supporting them as they face a bid for control of the company by a former Board member. The group assumed leadership in August 2011.

 

 

Read More


Cryo-Cell Leadership Sets the Record Straight on Efforts to Date

Cryo-Cell International, Inc. [OTCQB Symbol: CCEL] updated shareholders with results achieved by the current Board's leadership, which is being challenged for control of the company by previous Board members Ki Yong Choi and his brother-in-law.

 

 

Read More


Cryo-Cell Reports Financial Results For Fiscal 2011

“Cryo-Cell fiscal 2011 results are indicative of a company that is in the process of making many organizational and operational improvements,” stated David Portnoy, Cryo-Cell’s Chairman and Co-CEO. “Although the implementation of these steps is still in the early stages, we are encouraged in our belief that our goals will be achieved.”

 

 

Read More


Request Investor Information

Send me press release announcements by email: